These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 21776473)

  • 1. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
    Monagas M; Urpi-Sarda M; Sánchez-Patán F; Llorach R; Garrido I; Gómez-Cordovés C; Andres-Lacueva C; Bartolomé B
    Food Funct; 2010 Dec; 1(3):233-53. PubMed ID: 21776473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative biokinetics and metabolism of pure monomeric, dimeric, and polymeric flavan-3-ols: a randomized cross-over study in humans.
    Wiese S; Esatbeyoglu T; Winterhalter P; Kruse HP; Winkler S; Bub A; Kulling SE
    Mol Nutr Food Res; 2015 Apr; 59(4):610-21. PubMed ID: 25546356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of formulation and processing on absorption and metabolism of flavan-3-ols from tea and cocoa.
    Neilson AP; Ferruzzi MG
    Annu Rev Food Sci Technol; 2011; 2():125-51. PubMed ID: 22129378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans.
    Calani L; Del Rio D; Luisa Callegari M; Morelli L; Brighenti F
    Int J Food Sci Nutr; 2012 Aug; 63(5):513-21. PubMed ID: 22133145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity.
    Mena P; Bresciani L; Brindani N; Ludwig IA; Pereira-Caro G; Angelino D; Llorach R; Calani L; Brighenti F; Clifford MN; Gill CIR; Crozier A; Curti C; Del Rio D
    Nat Prod Rep; 2019 May; 36(5):714-752. PubMed ID: 30468210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites.
    Cueva C; Sánchez-Patán F; Monagas M; Walton GE; Gibson GR; Martín-Álvarez PJ; Bartolomé B; Moreno-Arribas MV
    FEMS Microbiol Ecol; 2013 Mar; 83(3):792-805. PubMed ID: 23121387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.
    Redan BW; Chegeni M; Ferruzzi MG
    Food Funct; 2017 Jan; 8(1):111-121. PubMed ID: 27808339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo.
    Spencer JP; Schroeter H; Rechner AR; Rice-Evans C
    Antioxid Redox Signal; 2001 Dec; 3(6):1023-39. PubMed ID: 11813978
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Pulido-Mateos EC; Lessard-Lord J; Desjardins Y; Roy D
    J Agric Food Chem; 2024 Oct; 72(39):21677-21689. PubMed ID: 39304182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Faecal Fermentation of Monomeric and Oligomeric Flavan-3-ols: Catabolic Pathways and Stoichiometry.
    Di Pede G; Bresciani L; Brighenti F; Clifford MN; Crozier A; Del Rio D; Mena P
    Mol Nutr Food Res; 2022 Nov; 66(21):e2101090. PubMed ID: 35107868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats.
    Tsang C; Auger C; Mullen W; Bornet A; Rouanet JM; Crozier A; Teissedre PL
    Br J Nutr; 2005 Aug; 94(2):170-81. PubMed ID: 16115350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols.
    Clifford MN; van der Hooft JJ; Crozier A
    Am J Clin Nutr; 2013 Dec; 98(6 Suppl):1619S-1630S. PubMed ID: 24172307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capability of Lactobacillus plantarum IFPL935 to catabolize flavan-3-ol compounds and complex phenolic extracts.
    Sánchez-Patán F; Tabasco R; Monagas M; Requena T; Peláez C; Moreno-Arribas MV; Bartolomé B
    J Agric Food Chem; 2012 Jul; 60(29):7142-51. PubMed ID: 22646528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial Metabolites of Flavan-3-Ols and Their Biological Activity.
    Márquez Campos E; Stehle P; Simon MC
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31546992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the bioavailability of flavan-3-ols in humans: A systematic review and comprehensive data analysis.
    Di Pede G; Mena P; Bresciani L; Achour M; Lamuela-Raventós RM; Estruch R; Landberg R; Kulling SE; Wishart D; Rodriguez-Mateos A; Crozier A; Manach C; Del Rio D
    Mol Aspects Med; 2023 Feb; 89():101146. PubMed ID: 36207170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-individual variability in the production of flavan-3-ol colonic metabolites: preliminary elucidation of urinary metabotypes.
    Mena P; Ludwig IA; Tomatis VB; Acharjee A; Calani L; Rosi A; Brighenti F; Ray S; Griffin JL; Bluck LJ; Del Rio D
    Eur J Nutr; 2019 Jun; 58(4):1529-1543. PubMed ID: 29616322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells.
    Monagas M; Khan N; Andrés-Lacueva C; Urpí-Sardá M; Vázquez-Agell M; Lamuela-Raventós RM; Estruch R
    Br J Nutr; 2009 Jul; 102(2):201-6. PubMed ID: 19586571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Gut Microbiota's Ability to Metabolize Oligomeric and Polymeric Flavan-3-ols from Aronia and Cranberry.
    Lessard-Lord J; Roussel C; Guay V; Desjardins Y
    Mol Nutr Food Res; 2024 Mar; 68(5):e2300641. PubMed ID: 38350729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome.
    Tulipani S; Urpi-Sarda M; García-Villalba R; Rabassa M; López-Uriarte P; Bulló M; Jáuregui O; Tomás-Barberán F; Salas-Salvadó J; Espín JC; Andrés-Lacueva C
    J Agric Food Chem; 2012 Sep; 60(36):8930-40. PubMed ID: 22631214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proanthocyanidins and Flavan-3-ols in the Prevention and Treatment of Periodontitis-Immunomodulatory Effects, Animal and Clinical Studies.
    Nawrot-Hadzik I; Matkowski A; Kubasiewicz-Ross P; Hadzik J
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.